2023. Senolytic Therapeutics: Translating a Compelling Mouse Phenotype Into a Testable Human Endpoint. Translational Medicine & Therapeutics Journal. 2, 1 (Feb. 2023), 10–18. DOI:https://doi.org/10.5281/zenodo.22649028.